Skip to content

Comparison of Volume Assist Control, Dual Mode and Airway Pressure Release Ventilation.

Comparison of Volume Assist Control, Dual Mode and Airway Pressure Release Ventilation: A Physiological Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04196738
Acronym
COMIX-R
Enrollment
20
Registered
2019-12-12
Start date
2020-06-30
Completion date
2022-10-26
Last updated
2024-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ARDS

Brief summary

The aim of the COMIX-R study is to assess the short term physiological effects of 3 ventilation strategies for adult patients with ARDS admitted to intensive care unit

Interventions

Patients are ventilated in randomised order with three different ventilation strategies: volume assist control (constant flow), Dual Mode or Airway Pressure Released Ventilation

Sponsors

University Hospital, Angers
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
NONE

Intervention model description

patients exposed to 3 ventilatory mode in 2 different possible orders

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years or older * Invasive mechanical ventilation on tracheal probe * Acute respiratory distress syndrome, as defined by Berlin conference consensus, during hospitalization in intensive care, * Recovery phase of acute respiratory distress syndrome: spontaneous ventilation representing from 20 to 30% of ventilation in APRV mode. * No severe acidosis (pH\> 7.30) * Patient affiliated to or beneficiary of a health care plan * Express consent of the patient or his/her SDM

Exclusion criteria

* Pneumothorax * Contraindication to the insertion of a nasogastric tube with an esophageal balloon * Contraindication to the use of Electrical impedance tomography (pacemaker) * Pregnancy, lactating or parturient woman

Design outcomes

Primary

MeasureTime frameDescription
change of PaO2 (mmHg)15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutesArterial partial pressure of dioxygen Of note: As it is a physiological study, all the primary and secondary outcomes will be analyzed with the same importance.

Secondary

MeasureTime frameDescription
-PEEPi15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutesintrinsic positive end-expiratory pressure (cm H20)
MAP15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutesmean arterial pressure
HR15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutesheart rate (beats per minute)
-Respiratory comfort15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutesvisual analogic scale
-Patient-ventilator asynchronies15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutesnumbers of asynchronies analyzed on screen
-Respiratory rate variability15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutesvariability of rate (per minute)
-P0.115 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutespressure measured during the first 100 ms after an occlusion (cm H20)
-ventilation distribution in the lungs15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutesElectrical impedance tomography (EIT) assess distribution of tidal volume and of end-expiratory lung volume (EELV) (delta Z, IU)
-other arterial parameters of hematosis15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutespH, PaO2, PaCo2 (mmHg)
-Work of breathing (WOB)15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutescalculated with esophageal pressure (Kg/m)
-Pressure time product (PTP)15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutes-Pressure time product (PTP) calculated with esophageal pressure (cmH2O.s.min-1)
-Tidal volume variability15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutesvariability of Tidal volume (mL)
-expiratory and inspiratory transpulmonary pressure15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutescalculated with the esophageal pressure (cm H20)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026